What are the dosing guidelines for Augmentin (amoxicillin/clavulanate) in adults and children, including adjustments for renal impairment and alternatives for penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing Guidelines

For most common infections in adults, use Augmentin 875-125 mg every 12 hours or 500-125 mg every 8 hours; for children, use high-dose amoxicillin-clavulanate at 90 mg/kg/day (amoxicillin component) divided every 12 hours for resistant infections, or 45 mg/kg/day divided every 8-12 hours for standard coverage. 1

Adult Dosing

Standard Dosing (Normal Renal Function)

  • Complicated UTI/Pyelonephritis: 875-125 mg every 8-12 hours 2, 3
  • Acute Bacterial Rhinosinusitis: High-dose formulation (2 g orally twice daily) is recommended for initial empiric therapy 4
  • Community-Acquired Pneumonia: Standard oral dosing for step-down therapy after clinical improvement 5

Renal Impairment Adjustments

Critical consideration: Amoxicillin and clavulanate have differential renal clearance, requiring careful dose adjustment 6

  • CrCl 10-30 mL/min: Reduce frequency or dose; the amoxicillin-to-clavulanate ratio increases significantly (from 4.9:1 to 11.9:1) as renal function declines 6
  • CrCl <10 mL/min or hemodialysis: Further dose reduction required; hemodialysis removes both components but clavulanate has higher extraction ratio (0.74 vs 0.44 for amoxicillin) 7
  • Augmented renal clearance (ICU patients): May require higher doses or more frequent dosing; renal function is the primary determinant of exposure, not body weight 8

Pediatric Dosing

Standard Formulations

For acute otitis media and resistant pneumococcal infections: Use AUGMENTIN ES-600 at 90 mg/kg/day (amoxicillin component) divided every 12 hours for 10 days 1

  • Body weight-based dosing (ES-600 formulation):
    • 8 kg: 3.0 mL twice daily
    • 12 kg: 4.5 mL twice daily
    • 16 kg: 6.0 mL twice daily
    • 20 kg: 7.5 mL twice daily
    • 24 kg: 9.0 mL twice daily 1

Community-Acquired Pneumonia

  • Outpatient (<5 years): Amoxicillin-clavulanate 90 mg/kg/day in 2 doses (amoxicillin component) 5
  • Outpatient (≥5 years): 90 mg/kg/day in 2 doses, maximum 4 g/day 5
  • Inpatient: Consider parenteral therapy initially, then step-down to oral when clinically improving 5

Critical Care Considerations

Post-cardiac surgery patients with augmented clearance: Require 4-hourly dosing instead of standard 6-hourly dosing to maintain adequate drug exposure, except when on vasopressors (which decrease clearance by 1/3) 9

Key Clinical Pitfalls

Formulation Confusion

AUGMENTIN ES-600 is NOT interchangeable with other Augmentin suspensions due to different clavulanate content:

  • ES-600: 42.9 mg clavulanate per 5 mL
  • 200 mg/5 mL suspension: 28.5 mg clavulanate per 5 mL
  • 400 mg/5 mL suspension: 57 mg clavulanate per 5 mL 1

Oral Beta-Lactam Limitations

For complicated UTI, oral beta-lactams (including amoxicillin-clavulanate) show inferior outcomes compared to fluoroquinolones or trimethoprim-sulfamethoxazole in most comparative studies, despite optimized dosing 2, 3. Consider this when selecting oral step-down therapy.

Bioavailability Considerations

  • Amoxicillin oral absorption: 80% 2, 3
  • Clavulanate absorption: Variable 2, 3
  • Urinary excretion: 50-70% (amoxicillin), 25-40% (clavulanate) 2, 3
  • Administration: Take at start of meals to minimize GI intolerance and enhance clavulanate absorption 1

Penicillin Allergy Alternatives

Immediate-Type Reactions

  • Recent (≤5 years) or severe reactions: Avoid all penicillins; use alternatives such as fluoroquinolones, cephalosporins (if no cross-reactivity), or clindamycin depending on infection type 10
  • Non-severe reactions (>5 years ago): May consider controlled drug challenge with amoxicillin 500 mg under observation 10

Cross-Reactivity

For patients with documented penicillin allergy, cephalosporins may be used cautiously if the penicillin reaction was non-severe and occurred >5 years ago 10. However, avoid in patients with anaphylaxis or severe cutaneous adverse reactions (SCAR) to penicillins 10.

Duration of Therapy

  • Acute bacterial rhinosinusitis (adults): 5-7 days 4
  • Acute bacterial rhinosinusitis (children): 10-14 days 4
  • Acute otitis media (children): 10 days 1
  • Complicated UTI: Continue until 24-48 hours after defervescence and clinical improvement 2

Monitoring Requirements

  • Hepatic function: Monitor at regular intervals in hepatically impaired patients 1
  • Renal function: Essential in ICU patients and those with renal impairment; clearance changes rapidly with recovery or deterioration 8
  • Clinical response: Reassess at 48-72 hours; consider alternative therapy if no improvement 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.